A prospective study of the incidence, associations and outcomes of ocular surface squamous neoplasia in the United Kingdom

To describe the incidence, associations and outcomes of ocular surface squamous neoplasia (OSSN) in the United Kingdom. Prospective, observational study of every new case of OSSN reported via the British Ophthalmological Surveillance Unit reporting scheme over a 12-month period. Cases were followed...

Full description

Saved in:
Bibliographic Details
Published in:Eye (London) Vol. 33; no. 2; pp. 283 - 294
Main Authors: Kiire, Christine A, Stewart, Rosalind M K, Srinivasan, Sathish, Heimann, Heinrich, Kaye, Stephen B, Dhillon, Baljean
Format: Journal Article
Language:English
Published: England Nature Publishing Group 01.02.2019
Subjects:
Accreditation
Acuity
Adult
Aged
Aged, 80 and over
Antibiotics, Antineoplastic - therapeutic use
Carcinoma in Situ - epidemiology
Carcinoma in Situ - pathology
Carcinoma in Situ - therapy
Carcinoma, Squamous Cell - epidemiology
Carcinoma, Squamous Cell - pathology
Carcinoma, Squamous Cell - therapy
Conjunctival Neoplasms - epidemiology
Conjunctival Neoplasms - pathology
Conjunctival Neoplasms - therapy
Cryotherapy
Disease management
Female
Follow-Up Studies
Glucocorticoids - therapeutic use
Health education
Humans
Incidence
Interferon
Male
Middle Aged
Ophthalmologic Surgical Procedures
Pain
Patients
Prospective Studies
Risk Factors
Squamous cell carcinoma
Surveys and Questionnaires
Treatment Outcome
United Kingdom - epidemiology
United Kingdom
United Kingdom > UK
ISSN:0950-222X, 1476-5454, 1476-5454
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To describe the incidence, associations and outcomes of ocular surface squamous neoplasia (OSSN) in the United Kingdom. Prospective, observational study of every new case of OSSN reported via the British Ophthalmological Surveillance Unit reporting scheme over a 12-month period. Cases were followed up for 12 months. The reported incidence of OSSN was 0.53 cases/million/year (conjunctival intraepithelial neoplasia: 0.43 cases/million/year; squamous cell carcinoma: 0.08 cases/million/year). Eighty-five per cent of affected patients were male, 97% were Caucasian, and the mean age at presentation was 67.9 (±12.8) years. Information on potential underlying risk factors was frequently unknown. The most commonly affected sites were the limbus and the nasal and temporal bulbar conjunctivae. Most patients presented with a visual acuity of 6/9 or better, without symptoms of pain or visual loss. Excision (with or without additional treatment) was the most common first-line treatment and interferon (with or without additional treatment) was the most common second-line treatment, although management varied widely. Complications of treatment were rare but occasionally severe. Recurrence within 12 months of follow-up occurred in at least 6% of patients. Although subject to reporting bias, these data suggest that there has not been a significant change in the incidence of OSSN in the United Kingdom, or its demographic profile, since 1996. The broad range of management approaches identified in this study reflect a lack of consensus as to the optimal referral and treatment pathways.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0950-222X
1476-5454
1476-5454
DOI:10.1038/s41433-018-0217-x